Abstract
The Quality of Life Committee of the National Cancer Institute of Canada Clinical Trials Group has successfully advocated the adoption of quality of life outcomes in Canadian clinical trials in patients with cancer. It has developed a policy promoting quality of life assessment in phase III trials and developed writing guidelines to assist clinical investigators when developing protocols for proposed studies. As a result, all phase III clinical trials instituted since the policy was developed have quality of life assessment as a part of their objectives. It has assisted the Clinical Trials Group office personnel in the development of procedures for the conduct of quality of life assessments in clinical trials with the result that the completion rate of self-report questionnaires is very high. The Committee maintains contact with other clinical trials groups and organizations having an interest in measuring quality of life in cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Osoba D. Measuring the effect of cancer on quality of life. In: Osoba D, ed.Effect of Cancer on Quality of Life. Boca Raton: CRC Press, 1991: 26–40.
Levine MN. Incorporation of quality of life assessment into clinical trials. In: Osoba D, ed.Effect of Cancer on Quality of Life. Boca Raton: CRC Press, 1991: 106–111.
Osoba D, Aaronson NK, Till JE. A practical guide for selecting quality of life measures in clinical trials and practice. In: Osoba D, ed.Effect of Cancer on Quality of Life. Boca Raton: CRC Press, 1991: 90–104.
Aaronson NK, Ahmedzai S, Bullinger M, et al. The EORTC core quality-of-life questionnaire: interim results of an international field study. In: Osoba D, ed.Effect of Cancer on Quality of Life. Boca Raton: CRC Press, 1991: 185–203.
Levine MN, Guyatt GH, Gent M et al. Quality of life stage II breast cancer: an instrument for clinicial trials.J Clin Oncol 1988;6: 1798–1810.
Sadura A, Pater J, Levine M,et al. Quality of life assessment: patient compliance with questionnaire completion. Society for Clinical Trials, International Society for Clinical Biostatistics Joint Meeting. Brussels, Belgium. 1991 (Abstract).
Schipper H, Clinch J, McMurray A, et al. Measuring quality of life in cancer patients: The Functional Living Index-Cancer: development and validation.J Clin Oncol 1984;2: 472–483.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Osoba, D. The Quality of Life Committee of the Clinical Trials Group of the National Cancer Institute of Canada: organization and functions. Qual Life Res 1, 211–218 (1992). https://doi.org/10.1007/BF00635620
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00635620